Search research articles
Contact Us
Filters
Showing results (31-40 of 71) with videos related to
Page
of 8
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)
|
August 1, 1984
Preparation and characterization of monoclonal antibodies recognizing three distinct differentiation antigens (BL1, BL2, BL3) on human B lymphocytes
C Y Wang, W Azzo, A Al-Katib, et al.
Oncogene
|
October 1, 1988
Modulation of c-myc oncogene expression by phorbol ester and interferon-gamma: appraisal by flow cytometry
A N Mohamed, A Nakeff, R M Mohammad, et al.
Leukemia Research
|
May 1, 1997
Bryostatin 1 (bryo1)-induced monocytic differentiation in THP-1 human leukemia cells is associated with enhanced c-fyn tyrosine kinase and M-CSF receptors
Y Li, R M Mohammad, A al-Katib, et al.
Cancer Genetics and Cytogenetics
|
February 1, 1996
Clonal evolution of chronic lymphocytic leukemia to acute lymphoblastic leukemia
A N Mohamed, R Compean, M E Dan, et al.
Cancer Gene Therapy
|
September 1, 1995
Antisense oligodeoxyribonucleotide down-regulation of bcl-2 gene expression inhibits growth of the low-grade non-Hodgkin's lymphoma cell line WSU-FSCCL
M R Smith, Y Abubakr, R Mohammad, et al.
The Journal of Experimental Medicine
|
November 1, 1983
Induction of HLA-DC/DS (LEU 10) antigen expression by human precursor B cell lines
C Y Wang, A Al-Katib, C L Lane, et al.
Cancer
|
March 15, 1992
A human B-cell lymphoma line with a de novo multidrug resistance phenotype
R M Mohammad, A N Mohamed, M KuKuruga, et al.
Blood
|
December 31, 1997
The novel cyclin-dependent kinase inhibitor flavopiridol downregulates Bcl-2 and induces growth arrest and apoptosis in chronic B-cell leukemia lines
A König, G K Schwartz, R M Mohammad, et al.
Radiation Oncology Investigations
|
July 16, 1999
Radiobiological characterization of two human chemotherapy-resistant intermediate grade non-Hodgkin's lymphoma cell lines
A Aref, R Mohammad, M Yudelev, et al.
Cancer Genetics and Cytogenetics
|
October 1, 1993
A unique EBV-negative low-grade lymphoma line (WSU-FSCCL) exhibiting both t(14;18) and t(8;11)
R M Mohammad, A N Mohamed, M R Smith, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 71) with videos related to
Sort By:
Page
of 8
Journal of Immunology (Baltimore, Md. : 1950)
|
August 1, 1984
Preparation and characterization of monoclonal antibodies recognizing three distinct differentiation antigens (BL1, BL2, BL3) on human B lymphocytes
C Y Wang, W Azzo, A Al-Katib, et al.
Oncogene
|
October 1, 1988
Modulation of c-myc oncogene expression by phorbol ester and interferon-gamma: appraisal by flow cytometry
A N Mohamed, A Nakeff, R M Mohammad, et al.
Leukemia Research
|
May 1, 1997
Bryostatin 1 (bryo1)-induced monocytic differentiation in THP-1 human leukemia cells is associated with enhanced c-fyn tyrosine kinase and M-CSF receptors
Y Li, R M Mohammad, A al-Katib, et al.
Cancer Genetics and Cytogenetics
|
February 1, 1996
Clonal evolution of chronic lymphocytic leukemia to acute lymphoblastic leukemia
A N Mohamed, R Compean, M E Dan, et al.
Cancer Gene Therapy
|
September 1, 1995
Antisense oligodeoxyribonucleotide down-regulation of bcl-2 gene expression inhibits growth of the low-grade non-Hodgkin's lymphoma cell line WSU-FSCCL
M R Smith, Y Abubakr, R Mohammad, et al.
The Journal of Experimental Medicine
|
November 1, 1983
Induction of HLA-DC/DS (LEU 10) antigen expression by human precursor B cell lines
C Y Wang, A Al-Katib, C L Lane, et al.
Cancer
|
March 15, 1992
A human B-cell lymphoma line with a de novo multidrug resistance phenotype
R M Mohammad, A N Mohamed, M KuKuruga, et al.
Blood
|
December 31, 1997
The novel cyclin-dependent kinase inhibitor flavopiridol downregulates Bcl-2 and induces growth arrest and apoptosis in chronic B-cell leukemia lines
A König, G K Schwartz, R M Mohammad, et al.
Radiation Oncology Investigations
|
July 16, 1999
Radiobiological characterization of two human chemotherapy-resistant intermediate grade non-Hodgkin's lymphoma cell lines
A Aref, R Mohammad, M Yudelev, et al.
Cancer Genetics and Cytogenetics
|
October 1, 1993
A unique EBV-negative low-grade lymphoma line (WSU-FSCCL) exhibiting both t(14;18) and t(8;11)
R M Mohammad, A N Mohamed, M R Smith, et al.
Page
of 8